Bausch & Lomb (BLCO) Total Non-Current Liabilities (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Total Non-Current Liabilities came in at $7.0 billion in Q2 2026, down 3.43% on a YoY basis from $7.2 billion in Q2 2025, and up 1.6% quarter-over-quarter from $6.9 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Total Non-Current Liabilities for 6 consecutive years, with $7.0 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 3.43% year-over-year to $7.0 billion; the trailing twelve-month figure through Jun 2026 stood at $7.0 billion (down 3.43% YoY), and the FY2025 full-year result was $7.0 billion, up 7.5% from the prior year.
- Total Non-Current Liabilities improved to $7.0 billion in Q2 2026 per BLCO's latest filing, from $6.9 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $7.2 billion in Q2 2025 and bottomed at $3.7 billion in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $5.8 billion across 5 years, with a median of $6.5 billion in 2024.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities jumped 230.72% in 2022, then slipped 3.43% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $3.7 billion in 2022, then surged by 64.92% to $6.1 billion in 2023, then gained by 6.04% to $6.5 billion in 2024, then climbed by 7.5% to $7.0 billion in 2025, then declined by 0.03% to $7.0 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $7.0 billion, $6.9 billion, and $7.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 6.98 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.98 Bn |
| Mar 31, 2026 | 6.87 Bn |
| Dec 31, 2025 | 6.98 Bn |
| Sep 30, 2025 | 6.83 Bn |
| Jun 30, 2025 | 7.23 Bn |
| Mar 31, 2025 | 6.88 Bn |
| Dec 31, 2024 | 6.50 Bn |
| Sep 30, 2024 | 6.81 Bn |
| Jun 30, 2024 | 6.63 Bn |
| Mar 31, 2024 | 6.52 Bn |
| Dec 31, 2023 | 6.13 Bn |
| Sep 30, 2023 | 6.14 Bn |
| Jun 30, 2023 | 4.28 Bn |
| Mar 31, 2023 | 4.11 Bn |
| Dec 31, 2022 | 3.71 Bn |
| Sep 30, 2022 | 3.90 Bn |
| Jun 30, 2022 | 4.03 Bn |
| Mar 31, 2022 | 3.68 Bn |
| Dec 31, 2021 | 1.12 Bn |